George Calin: New Findings on β-Adrenergic Signaling in TP53-Mutant Oral Squamous Cell Carcinoma
George Calin/LinkedIn

George Calin: New Findings on β-Adrenergic Signaling in TP53-Mutant Oral Squamous Cell Carcinoma

George Calin, Professor at MD Anderson Cancer Center, Editor-in-Chief of Molecular Aspects of Medicine, posted on LinkedIn:

“With mixed emotions about this discovery by Deborah, Fred, Tongxin and the entire team: I am happy about the groundbreaking findings and deeply appreciative of the years of dedicated work put into the project!

At the same time, saddened that Deb didn’t have the chance to witness this moment…
We miss you, Deb! Your hard work and passion brought this wonderful project to fruition! Thank You!

About how a neuro-immune axis reverses immune escape in p53-deficient HNSCC.”

Title: β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell Carcinoma

Authors: Frederico Gleber-Netto, Deborah Silverman, Tongxin Xie, Shamima Akhter, Nicole Vaughn, Adewale Adebayo, Kala Chand Debnath, Shorook Naara, Shajedul Islam, Erik Knutsen, Emily Lorin Ashkin, Simone Anfossi, Sara Leahey, Patrick Hwu, Sebastien Talbot, Erica Sloan, Robert Saddawi-Konefka, Roberto Rangel, Jeffrey Myers, George Calin, Moran Amit

Read the Full Article in The Advanced.
George Calin: New Findings on β-Adrenergic Signaling in TP53-Mutant Oral Squamous Cell Carcinoma

More posts featuring George Calin.